JPWO2021097376A5 - - Google Patents

Info

Publication number

JPWO2021097376A5

JPWO2021097376A5 JP2022527993A JP2022527993A JPWO2021097376A5 JP WO2021097376 A5 JPWO2021097376 A5 JP WO2021097376A5 JP 2022527993 A JP2022527993 A JP 2022527993A JP 2022527993 A JP2022527993 A JP 2022527993A JP WO2021097376 A5 JPWO2021097376 A5 JP WO2021097376A5

Authority

JP

Japan

Prior art keywords

polypeptide

cytokine

fusion polypeptide

pharmaceutical composition

seq

Prior art date

2023-11-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims description 248
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 248
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 248
• 230000004927 fusion Effects 0.000 claims description 140
• 102000004127 Cytokines Human genes 0.000 claims description 74
• 108090000695 Cytokines Proteins 0.000 claims description 74
• 239000008194 pharmaceutical composition Substances 0.000 claims description 71
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 53
• 239000003814 drug Substances 0.000 claims description 48
• 229940124597 therapeutic agent Drugs 0.000 claims description 41
• 230000000903 blocking effect Effects 0.000 claims description 39
• 108010002350 Interleukin-2 Proteins 0.000 claims description 38
• 102000000588 Interleukin-2 Human genes 0.000 claims description 38
• 239000012634 fragment Substances 0.000 claims description 36
• 102000013462 Interleukin-12 Human genes 0.000 claims description 33
• 108010065805 Interleukin-12 Proteins 0.000 claims description 33
• 102000006992 Interferon-alpha Human genes 0.000 claims description 28
• 108010047761 Interferon-alpha Proteins 0.000 claims description 28
• 102000003996 Interferon-beta Human genes 0.000 claims description 28
• 108090000467 Interferon-beta Proteins 0.000 claims description 28
• 102000003675 cytokine receptors Human genes 0.000 claims description 28
• 108010057085 cytokine receptors Proteins 0.000 claims description 28
• 230000004913 activation Effects 0.000 claims description 25
• 230000000694 effects Effects 0.000 claims description 25
• 206010028980 Neoplasm Diseases 0.000 claims description 15
• 201000011510 cancer Diseases 0.000 claims description 15
• 229960001388 interferon-beta Drugs 0.000 claims description 14
• 102000035195 Peptidases Human genes 0.000 claims description 11
• 108091005804 Peptidases Proteins 0.000 claims description 11
• 239000004365 Protease Substances 0.000 claims description 11
• 238000003776 cleavage reaction Methods 0.000 claims description 11
• 230000007017 scission Effects 0.000 claims description 11
• 102000007562 Serum Albumin Human genes 0.000 claims description 10
• 108010071390 Serum Albumin Proteins 0.000 claims description 10
• 102100036842 C-C motif chemokine 19 Human genes 0.000 claims description 8
• 102100036848 C-C motif chemokine 20 Human genes 0.000 claims description 8
• 102100036846 C-C motif chemokine 21 Human genes 0.000 claims description 8
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 8
• 102000004172 Cathepsin L Human genes 0.000 claims description 8
• 108090000624 Cathepsin L Proteins 0.000 claims description 8
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims description 8
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims description 8
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims description 8
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 8
• 108010002586 Interleukin-7 Proteins 0.000 claims description 8
• 239000002955 immunomodulating agent Substances 0.000 claims description 8
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 8
• 230000003213 activating effect Effects 0.000 claims description 7
• 230000000295 complement effect Effects 0.000 claims description 7
• 102000008070 Interferon-gamma Human genes 0.000 claims description 6
• 108010074328 Interferon-gamma Proteins 0.000 claims description 6
• 229940079593 drug Drugs 0.000 claims description 6
• 229960003130 interferon gamma Drugs 0.000 claims description 6
• 239000000203 mixture Substances 0.000 claims description 6
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 5
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 5
• 239000000427 antigen Substances 0.000 claims description 5
• 102000036639 antigens Human genes 0.000 claims description 5
• 108091007433 antigens Proteins 0.000 claims description 5
• 230000002238 attenuated effect Effects 0.000 claims description 5
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 claims description 4
• 102000029791 ADAM Human genes 0.000 claims description 4
• 108091022885 ADAM Proteins 0.000 claims description 4
• ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 claims description 4
• 102000007590 Calpain Human genes 0.000 claims description 4
• 108010032088 Calpain Proteins 0.000 claims description 4
• 102000000496 Carboxypeptidases A Human genes 0.000 claims description 4
• 108010080937 Carboxypeptidases A Proteins 0.000 claims description 4
• 102000011727 Caspases Human genes 0.000 claims description 4
• 108010076667 Caspases Proteins 0.000 claims description 4
• 108090000617 Cathepsin G Proteins 0.000 claims description 4
• 102000004173 Cathepsin G Human genes 0.000 claims description 4
• 102000005600 Cathepsins Human genes 0.000 claims description 4
• 108010084457 Cathepsins Proteins 0.000 claims description 4
• 102100024539 Chymase Human genes 0.000 claims description 4
• 108090000227 Chymases Proteins 0.000 claims description 4
• 101000766307 Gallus gallus Ovotransferrin Proteins 0.000 claims description 4
• 101710088083 Glomulin Proteins 0.000 claims description 4
• 102000001398 Granzyme Human genes 0.000 claims description 4
• 108050003624 Granzyme M Proteins 0.000 claims description 4
• 108060003951 Immunoglobulin Proteins 0.000 claims description 4
• 108060005987 Kallikrein Proteins 0.000 claims description 4
• 102000001399 Kallikrein Human genes 0.000 claims description 4
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
• 101710180643 Leishmanolysin Proteins 0.000 claims description 4
• 102000005741 Metalloproteases Human genes 0.000 claims description 4
• 108010006035 Metalloproteases Proteins 0.000 claims description 4
• 108090000973 Myeloblastin Proteins 0.000 claims description 4
• 102100034681 Myeloblastin Human genes 0.000 claims description 4
• 102000016387 Pancreatic elastase Human genes 0.000 claims description 4
• 108010067372 Pancreatic elastase Proteins 0.000 claims description 4
• 108010001014 Plasminogen Activators Proteins 0.000 claims description 4
• 102000001938 Plasminogen Activators Human genes 0.000 claims description 4
• 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims description 4
• 206010038389 Renal cancer Diseases 0.000 claims description 4
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 4
• 108090000190 Thrombin Proteins 0.000 claims description 4
• 102000004338 Transferrin Human genes 0.000 claims description 4
• 108060005989 Tryptase Proteins 0.000 claims description 4
• 102000001400 Tryptase Human genes 0.000 claims description 4
• 239000000556 agonist Substances 0.000 claims description 4
• 239000000611 antibody drug conjugate Substances 0.000 claims description 4
• 229940049595 antibody-drug conjugate Drugs 0.000 claims description 4
• 239000002246 antineoplastic agent Substances 0.000 claims description 4
• 210000004027 cell Anatomy 0.000 claims description 4
• 229940000425 combination drug Drugs 0.000 claims description 4
• 229940127089 cytotoxic agent Drugs 0.000 claims description 4
• 102000018358 immunoglobulin Human genes 0.000 claims description 4
• 229940121354 immunomodulator Drugs 0.000 claims description 4
• 230000002584 immunomodulator Effects 0.000 claims description 4
• 201000010982 kidney cancer Diseases 0.000 claims description 4
• 239000011159 matrix material Substances 0.000 claims description 4
• 102000039446 nucleic acids Human genes 0.000 claims description 4
• 108020004707 nucleic acids Proteins 0.000 claims description 4
• 150000007523 nucleic acids Chemical class 0.000 claims description 4
• 244000309459 oncolytic virus Species 0.000 claims description 4
• 229940127126 plasminogen activator Drugs 0.000 claims description 4
• -1 radiotherapy Substances 0.000 claims description 4
• 238000001959 radiotherapy Methods 0.000 claims description 4
• 238000002560 therapeutic procedure Methods 0.000 claims description 4
• 229960004072 thrombin Drugs 0.000 claims description 4
• 239000012581 transferrin Substances 0.000 claims description 4
• 210000004881 tumor cell Anatomy 0.000 claims description 4
• 208000036142 Viral infection Diseases 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 230000009385 viral infection Effects 0.000 claims description 3
• 206010005003 Bladder cancer Diseases 0.000 claims description 2
• 208000003174 Brain Neoplasms Diseases 0.000 claims description 2
• 206010006187 Breast cancer Diseases 0.000 claims description 2
• 208000026310 Breast neoplasm Diseases 0.000 claims description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
• 206010033128 Ovarian cancer Diseases 0.000 claims description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
• 206010060862 Prostate cancer Diseases 0.000 claims description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
• 150000001413 amino acids Chemical class 0.000 claims description 2
• 238000012258 culturing Methods 0.000 claims description 2
• 102000037865 fusion proteins Human genes 0.000 claims description 2
• 108020001507 fusion proteins Proteins 0.000 claims description 2
• 201000005202 lung cancer Diseases 0.000 claims description 2
• 208000020816 lung neoplasm Diseases 0.000 claims description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
• 201000001441 melanoma Diseases 0.000 claims description 2
• 201000002528 pancreatic cancer Diseases 0.000 claims description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
• 238000011084 recovery Methods 0.000 claims description 2
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
• 102000010789 Interleukin-2 Receptors Human genes 0.000 claims 3
• 108010038453 Interleukin-2 Receptors Proteins 0.000 claims 3
• 102000008100 Human Serum Albumin Human genes 0.000 claims 2
• 108091006905 Human Serum Albumin Proteins 0.000 claims 2
• 230000001225 therapeutic effect Effects 0.000 claims 2
• 102000005962 receptors Human genes 0.000 claims 1
• 108020003175 receptors Proteins 0.000 claims 1
• 238000000034 method Methods 0.000 description 33